Hematology Diagnostics Market

During the forecast period, the Hematology Diagnostics Market will exhibit profitable growth.

The global hematology diagnostics market is rapidly expanding; it was worth $3,167.2 million in 2017 and is expected to reach $5,288.3 million by 2026. Increasing blood donation procedures and rising incidences of blood disorders, along with enhanced diagnostics and hematology testing technologies, drive the overall hematology diagnostics market’s growth.

A new technological evolution in automated hematology analyzers would also drive the overall market. Additionally, new standardized, automated sample collection, data processing, identification and testing, and ordering of new tests, among other processes, will further spur revenue growth during the forecast period.

Market Synopsis

The hematology consumables segment is expected to dominate the global market during the forecast period.

Overall, sales of hematology consumables are expanding significantly on a global scale. It is anticipated to continue its dominance during the forecast period. Rising demand for consumables, along with the diagnosis of blood disorders and other infections, will grow prominently.

Moreover, increasing volumes of diagnostic tests owing to growing awareness and incidence are also driving the market growth. A wide range of reagents and kits, stains, and others in the consumables segment incorporates experts to meet the dynamic demand.

The instrument segment is further divided into analyzers, flow cytometers, and others. Increased automation, which offers high reliability, sensitivity, and specificity along with higher safety and ease of operation, is estimated to be the primary growth factor driving the hematology instruments segment globally.

The diagnostic laboratories segment is expected to register higher growth by the end of 2026.

Diagnostic laboratories in the end-user segment are predicted to expand at a significant CAGR during the forecast period. The rising number of multispecialty diagnostic centers and the availability of advanced hematology products are fueling demand globally. Additionally, the automation of diagnostic tools is anticipated to reduce the overall cost of blood testing.

The rise in partnerships among market players and diagnostic laboratories is one factor that is likely to drive market growth. The adoption of fully automated analyzers, along with enhanced prognosis, infectious disease monitoring, diagnosis, and preliminary screening processes, will drive growth in the end-user segment.

Increasing demand for advanced equipment and the presence of established players hold North America in a dominant position.

North America will account for the largest revenue share of the global hematology diagnostics market. The use of advanced technologies for point-of-care tests, as well as rising incidences of diseases such as blood cancers, acute infectious diseases, liver diseases, and spleen diseases, are factors boosting growth in North America.

Asia Pacific is expected to grow at a significant pace owing to new technology expansion and the adoption of advanced diagnostic instruments. Enhanced healthcare services, along with improved government initiatives, will have a positive impact on the hematology diagnostics market.

The dominance of multinational manufacturers with strong product portfolios in the developed regions

Major players in the hematology diagnostics market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Siemens Healthineers, Mindray Medical International Limited, Danaher Corporation, Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Drew Scientific, Sysmex Corporation, EKF Diagnostics, Boule Diagnostics, HORIBA, Diatron MI Zrt., and others. Furthermore, new product launches and technology expansion in diagnostic laboratories will drive market growth in the future.

The rising prevalence of blood disorders and other target diseases, the dynamic shift from manual to automated hematology testing, and the competitive advantages offered by commercial service providers in developing countries will all contribute to the market’s overall growth on a global scale.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segment

The current report also includes qualitative and quantitative market valuation factors such as key market drivers, market trends, restraints, and opportunities to provide a more comprehensive understanding of the global hematology diagnostics market. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths.

Key questions are answered in this report.

• What are the current market trends and dynamics in the hematology diagnostics market, and what are the valuable opportunities for emerging players?
• How has laboratory automation affected the dynamics of the hematology diagnostics market?
• What are the impact of fully automated analyzers and their consumption in developed markets?
• Which segment accounts for the fastest CAGR during the forecast period?
• What is the impact of target diseases and other infectious diseases on the hematology diagnostics market?
• What are the market trends and dynamics in emerging markets such as India, Mexico, China, South Africa, Brazil, and the Gulf nations?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global HD Market Portraiture
2.2. Global HD Market, by Product Type, 2017 (US$ Mn)
2.3. Global HD Market, by End User, 2017 (US$ Mn)
2.4. Global HD Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Hematology Diagnostics (HD) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. HD Technologies: Future Trends
3.3. Current Scenario: Partnerships, Mergers & New Product Launches
3.4. Drivers
3.5. Challenges
3.6. Opportunities
3.7. Attractive Investment Proposition, by Geography, 2017
3.8. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Hematology Diagnostics (HD) Market, by Product Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Hematology Instrumentss
4.2.1. Hematology Analyzers
4.2.2. Flow Cytometers
4.2.3. Others
4.3. Hematology Consumables
4.3.1. Reagents
4.3.2. Stains
4.3.3. Controls & Calibrators
4.3.4. Others

Chapter 5. Global Hematology Diagnostics (HD) Market, by End User, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Diagnostic Laboratories
5.3. Hospitals & Clinics
5.4. Academic and Research Institutes

Chapter 6. Global Hematology Diagnostics (HD) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America HD Market Analysis, 2016 – 2026
6.2.1. North America HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.2.2. North America HD Market, by End User, 2016 – 2026 (US$ Mn)
6.2.3. North America HD Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe HD Market Analysis, 2016 – 2026
6.3.1. Europe HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe HD Market, by End User, 2016 – 2026 (US$ Mn)
6.3.3. Europe HD Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific HD Market Analysis, 2016 – 2026
6.4.1. Asia Pacific HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific HD Market, by End User, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific HD Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America HD Market Analysis, 2016 – 2026
6.5.1. Latin America HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America HD Market, by End User, 2016 – 2026 (US$ Mn)
6.5.3. Latin America HD Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) HD Market Analysis, 2016 – 2026
6.6.1. MEA HD Market, by Product Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA HD Market, by End User, 2016 – 2026 (US$ Mn)
6.6.3. MEA HD Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Bio-Rad Laboratories, Inc.
7.3. Siemens Healthineers
7.4. Mindray Medical International Limited
7.5. F. Hoffmann-La Roche Ltd.
7.6. Danaher Corporation
7.7. Nihon Kohden Corporation
7.8. Drew Scientific
7.9. Sysmex Corporation
7.10. EKF Diagnostics
7.11. Boule Diagnostics
7.12. HORIBA
7.13. Diatron MI Zrt.

List of Figures

FIG. 1 Global Hematology Diagnostics (HD) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global HD Market Segmentation
FIG. 4 Global HD Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global HD Market, by End User, 2017 (US$ Mn)
FIG. 6 Global HD Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key HD Manufacturers, 2017
FIG. 9 Global Hematology Instruments Market for Hematology Analyzers, 2016–2026 (US$ Mn)
FIG. 10 Global Hematology Instruments Market for Flow Cytometers, 2016–2026 (US$ Mn)
FIG. 11 Global Hematology Instruments Market for Others, 2016–2026 (US$ Mn)
FIG. 12 Global Hematology Consumables Market for Reagents, 2016–2026 (US$ Mn)
FIG. 13 Global Hematology Consumables Market for Stains, 2016–2026 (US$ Mn)
FIG. 14 Global Hematology Consumables Market for Controls and Calibrators, 2016–2026 (US$ Mn)
FIG. 15 Global Hematology Consumables Market for Others, 2016–2026 (US$ Mn)
FIG. 16 Global HD in Diagnostic Laboratories, 2016–2026 (US$ Mn)
FIG. 17 Global HD in Hospitals and Clinics, 2016–2026 (US$ Mn)
FIG. 18 Global HD in Academic and Research Institutes, 2016–2026 (US$ Mn)
FIG. 19 U.S. HD Market, 2016–2026 (US$ Mn)
FIG. 20 Canada HD Market, 2016–2026 (US$ Mn)
FIG. 21 U.K. HD Market, 2016–2026 (US$ Mn)
FIG. 22 Germany HD Market, 2016–2026 (US$ Mn)
FIG. 23 Rest of Europe HD Market, 2016–2026 (US$ Mn)
FIG. 24 Japan HD Market, 2016–2026 (US$ Mn)
FIG. 25 China HD Market, 2016–2026 (US$ Mn)
FIG. 26 Rest of Asia Pacific HD Market, 2016–2026 (US$ Mn)
FIG. 27 Brazil HD Market, 2016–2026 (US$ Mn)
FIG. 28 Mexico HD Market, 2016–2026 (US$ Mn)
FIG. 29 Rest of Latin America HD Market, 2016–2026 (US$ Mn)
FIG. 30 GCC HD Market, 2016–2026 (US$ Mn)
FIG. 31 Rest of Middle East & Africa HD Market, 2016–2026 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Hematology Diagnostics (HD) Market
TABLE 2 Global HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 3 Global HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 4 Global HD Market, by Geography, 2016–2026 (US$ Mn)
TABLE 5 North America HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 6 North America HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 7 North America HD Market, by Country, 2016–2026 (US$ Mn)
TABLE 8 Europe HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 9 Europe HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 10 Europe HD Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 11 Asia Pacific HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 12 Asia Pacific HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 13 Asia Pacific HD Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 14 Latin America HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 15 Latin America HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 16 Latin America HD Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 17 Middle East & Africa HD Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 18 Middle East & Africa HD Market, by End User, 2016–2026 (US$ Mn)
TABLE 19 Middle East & Africa HD Market, by Region, 2016–2026 (US$ Mn)
TABLE 20 Abbott Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Bio-Rad Laboratories, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Siemens Healthineers: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 Mindray Medical International Limited.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 F. Hoffmann-La Roche Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Danaher Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Nihon Kohden Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Drew Scientific: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Sysmex Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 EKF Diagnostics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Boule Diagnostics.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 HORIBA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Diatron MI Zrt.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)